The PD-1/PD-L pathway in rheumatic diseases
Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity...
Saved in:
| Published in | Journal of the Formosan Medical Association Vol. 120; no. 1; pp. 48 - 59 |
|---|---|
| Main Authors | , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Singapore
Elsevier B.V
01.01.2021
Elsevier |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity.
We analyzed the existing scientific literature dealing with this issue. In this review, the PD-1/PD-L pathway in the genetic susceptibility to and pathogenesis of rheumatic diseases is discussed. The PD-1/PD-L pathway might be helpful for diagnosing, evaluating the disease activity of and treating rheumatic diseases.
PD-1/PD-L gene polymorphisms are associated with a genetic predisposition to rheumatic disorders, which can provide reference information for diagnosis and disease activity. The conclusion of the crucial role of the PD-1/PD-L pathway in the pathogenesis of rheumatic diseases is consistent, but the details remain controversial. In some animal models, manipulating the PD-1/PD-L pathway could decrease disease severity. PD-1/PD-Ls may enable us to develop new therapeutics for patients with rheumatic diseases in the future.
The PD-1/PD-L pathway plays crucial roles in rheumatic disease. More work is needed to provide a better mechanistic understanding of the PD-1/PD-L pathway and to facilitate the precise therapeutic manipulation of this pathway. |
|---|---|
| AbstractList | Background/purpose: Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity. Methods: We analyzed the existing scientific literature dealing with this issue. In this review, the PD-1/PD-L pathway in the genetic susceptibility to and pathogenesis of rheumatic diseases is discussed. The PD-1/PD-L pathway might be helpful for diagnosing, evaluating the disease activity of and treating rheumatic diseases. Results: PD-1/PD-L gene polymorphisms are associated with a genetic predisposition to rheumatic disorders, which can provide reference information for diagnosis and disease activity. The conclusion of the crucial role of the PD-1/PD-L pathway in the pathogenesis of rheumatic diseases is consistent, but the details remain controversial. In some animal models, manipulating the PD-1/PD-L pathway could decrease disease severity. PD-1/PD-Ls may enable us to develop new therapeutics for patients with rheumatic diseases in the future. Conclusion: The PD-1/PD-L pathway plays crucial roles in rheumatic disease. More work is needed to provide a better mechanistic understanding of the PD-1/PD-L pathway and to facilitate the precise therapeutic manipulation of this pathway. Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity. We analyzed the existing scientific literature dealing with this issue. In this review, the PD-1/PD-L pathway in the genetic susceptibility to and pathogenesis of rheumatic diseases is discussed. The PD-1/PD-L pathway might be helpful for diagnosing, evaluating the disease activity of and treating rheumatic diseases. PD-1/PD-L gene polymorphisms are associated with a genetic predisposition to rheumatic disorders, which can provide reference information for diagnosis and disease activity. The conclusion of the crucial role of the PD-1/PD-L pathway in the pathogenesis of rheumatic diseases is consistent, but the details remain controversial. In some animal models, manipulating the PD-1/PD-L pathway could decrease disease severity. PD-1/PD-Ls may enable us to develop new therapeutics for patients with rheumatic diseases in the future. The PD-1/PD-L pathway plays crucial roles in rheumatic disease. More work is needed to provide a better mechanistic understanding of the PD-1/PD-L pathway and to facilitate the precise therapeutic manipulation of this pathway. Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity.BACKGROUND/PURPOSEAutoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1) and its ligands (PD-Ls) have been discovered to be important negative regulators of the immune system, playing crucial roles in autoimmunity.We analyzed the existing scientific literature dealing with this issue. In this review, the PD-1/PD-L pathway in the genetic susceptibility to and pathogenesis of rheumatic diseases is discussed. The PD-1/PD-L pathway might be helpful for diagnosing, evaluating the disease activity of and treating rheumatic diseases.METHODSWe analyzed the existing scientific literature dealing with this issue. In this review, the PD-1/PD-L pathway in the genetic susceptibility to and pathogenesis of rheumatic diseases is discussed. The PD-1/PD-L pathway might be helpful for diagnosing, evaluating the disease activity of and treating rheumatic diseases.PD-1/PD-L gene polymorphisms are associated with a genetic predisposition to rheumatic disorders, which can provide reference information for diagnosis and disease activity. The conclusion of the crucial role of the PD-1/PD-L pathway in the pathogenesis of rheumatic diseases is consistent, but the details remain controversial. In some animal models, manipulating the PD-1/PD-L pathway could decrease disease severity. PD-1/PD-Ls may enable us to develop new therapeutics for patients with rheumatic diseases in the future.RESULTSPD-1/PD-L gene polymorphisms are associated with a genetic predisposition to rheumatic disorders, which can provide reference information for diagnosis and disease activity. The conclusion of the crucial role of the PD-1/PD-L pathway in the pathogenesis of rheumatic diseases is consistent, but the details remain controversial. In some animal models, manipulating the PD-1/PD-L pathway could decrease disease severity. PD-1/PD-Ls may enable us to develop new therapeutics for patients with rheumatic diseases in the future.The PD-1/PD-L pathway plays crucial roles in rheumatic disease. More work is needed to provide a better mechanistic understanding of the PD-1/PD-L pathway and to facilitate the precise therapeutic manipulation of this pathway.CONCLUSIONThe PD-1/PD-L pathway plays crucial roles in rheumatic disease. More work is needed to provide a better mechanistic understanding of the PD-1/PD-L pathway and to facilitate the precise therapeutic manipulation of this pathway. |
| Author | Zhang, Fengchun Zhang, Shuo Wang, Li Li, Mengtao Zeng, Xiaofeng |
| Author_xml | – sequence: 1 givenname: Shuo surname: Zhang fullname: Zhang, Shuo – sequence: 2 givenname: Li surname: Wang fullname: Wang, Li email: wangli2221@sina.com – sequence: 3 givenname: Mengtao surname: Li fullname: Li, Mengtao – sequence: 4 givenname: Fengchun surname: Zhang fullname: Zhang, Fengchun – sequence: 5 givenname: Xiaofeng surname: Zeng fullname: Zeng, Xiaofeng |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/32334916$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU9v1DAQxS1URLeFL8AB5YiEknocx7ERl6oUqLQSHMrZmjgT1iF_FjsL2m9fL9ty6KFcxtLo_d5Y752xk2meiLHXwAvgoC76ou9GLAQXvOCy4Fw-YyvQtcq5FnDCVtwIkysl1Sk7i7FPAmWMesFOS1GW0oBasXe3G8q-fczhIo11tsVl8wf3mZ-ysKHdiIt3WesjYaT4kj3vcIj06v49Z98_Xd9efcnXXz_fXF2uc1dBveSoZE3KISCvQYMgU6HpHNYlUJp1q2QjDXGq2oqLklwpWmNqTUCag2jLc3Zz9G1n7O02-BHD3s7o7d_FHH5YDOljA1mZvCqHjW60lqJpmpaaDqRC2SgAbZLX26PXNsy_dhQXO_roaBhwonkXrShNJSpTgU7SN_fSXTNS--_wQ1hJoI8CF-YYA3XW-SUlNE9LQD9Y4PbQi-3toRd76MVyaVPsCRWP0Af3J6EPR4hS2L89BRudp8lR6wO5JaXhn8bfP8Ld4CfvcPhJ-__BdwTStmY |
| CitedBy_id | crossref_primary_10_3389_fimmu_2022_946456 crossref_primary_10_1016_j_intimp_2024_113912 crossref_primary_10_1111_sji_13230 crossref_primary_10_1007_s10067_023_06761_y crossref_primary_10_1002_eji_202451465 crossref_primary_10_1177_10760296231187896 crossref_primary_10_3390_biom13020240 crossref_primary_10_3389_fimmu_2022_883733 crossref_primary_10_1016_j_ejr_2021_02_005 crossref_primary_10_1111_imm_13755 crossref_primary_10_3389_fimmu_2020_563784 crossref_primary_10_3389_fimmu_2023_1111005 crossref_primary_10_1007_s10238_022_00908_y crossref_primary_10_1186_s12859_023_05556_x crossref_primary_10_12677_ACM_2022_12101283 crossref_primary_10_1007_s00296_022_05247_5 crossref_primary_10_1080_08820139_2023_2250818 crossref_primary_10_3389_fcell_2021_790386 crossref_primary_10_1016_j_imlet_2020_09_001 crossref_primary_10_1016_j_biopha_2023_114215 crossref_primary_10_3389_fimmu_2022_838636 crossref_primary_10_3390_ijms251910676 crossref_primary_10_1002_cyto_b_22070 crossref_primary_10_1002_jcp_30855 crossref_primary_10_3389_fimmu_2023_1163633 crossref_primary_10_1016_j_currproblcancer_2022_100864 crossref_primary_10_1007_s11154_023_09846_w |
| Cites_doi | 10.1038/ni.1877 10.1186/s13075-014-0497-x 10.1016/j.jns.2018.01.030 10.1016/j.ctrv.2017.05.003 10.1212/WNL.0000000000004359 10.1002/art.27500 10.1136/annrheumdis-2016-209595 10.1016/S1074-7613(00)80089-8 10.1111/j.1572-0241.2006.00948.x 10.1038/ng1020 10.3389/fimmu.2017.00851 10.1002/acr.23177 10.1084/jem.191.5.891 10.1111/1346-8138.13339 10.5582/bst.2016.01171 10.1007/s10753-013-9718-8 10.1093/intimm/8.5.765 10.1038/s41551-019-0360-0 10.1084/jem.20112741 10.1093/rheumatology/kex346 10.1136/annrheumdis-2017-212257 10.1038/70932 10.1200/JCO.2017.77.0305 10.1016/j.autrev.2012.02.001 10.1097/MAJ.0000000000000468 10.1136/annrheumdis-2017-211216 10.1111/j.1365-2133.2011.10274.x 10.18632/oncotarget.16378 10.1186/s13075-015-0859-z 10.3390/ijms16047413 10.3389/fped.2017.00104 10.1002/art.24227 10.1016/j.clim.2015.10.006 10.1038/s41409-018-0162-0 10.1001/jamaneurol.2017.1912 10.1007/s11882-013-0404-6 10.1002/eji.201746923 10.1111/cas.12961 10.1007/s00296-009-1249-0 10.1002/eji.201040690 10.1007/s12016-011-8285-8 10.4049/jimmunol.0901652 10.1006/geno.1994.1562 10.3390/ijms16059794 10.1038/ni1443 10.3389/fimmu.2018.01677 10.1007/s00005-016-0404-z 10.3899/jrheum.170544 10.1080/14397595.2018.1469581 10.1053/j.seminoncol.2017.12.001 10.1093/rheumatology/ken256 10.1177/0961203308099176 10.1002/art.20436 10.4049/jimmunol.1001597 10.1155/2009/406136 10.1093/annonc/mdw443 10.1097/00019052-200410000-00006 10.1111/j.1440-1827.2007.02129.x 10.4049/jimmunol.177.12.8844 10.1016/j.autrev.2017.05.002 10.1097/CJI.0000000000000196 10.1172/JCI65325 10.1093/annonc/mdw126 10.1038/sj.ejhg.5201767 10.1038/sj.gene.6364360 10.1111/cei.12956 10.1016/j.autrev.2013.05.003 10.1007/s00296-015-3327-9 10.1371/journal.pone.0025345 10.1007/s00776-014-0648-6 10.1016/j.jtho.2017.02.024 10.18632/oncotarget.5665 10.1016/j.molimm.2011.06.436 10.3109/08916934.2015.1058370 10.1146/annurev.immunol.26.021607.090331 10.1111/hepr.12305 10.1002/art.40164 10.1007/s11910-018-0878-7 10.3390/cells7100161 10.1016/j.molimm.2011.09.014 10.1111/cei.12949 10.1159/000480641 10.1038/nature20810 10.1136/rmdopen-2016-000412 10.3109/03009742.2013.869830 10.1056/NEJMoa1609214 10.1038/85330 10.1186/s13075-017-1258-4 10.1007/s10067-011-1721-6 10.1007/s10038-007-0145-2 10.1002/art.27417 10.1016/j.jaut.2016.12.009 10.1016/j.clim.2014.04.010 10.4049/jimmunol.1202382 10.4049/jimmunol.170.3.1257 10.1002/art.20966 10.1002/art.20040 10.1002/art.20280 10.1097/MD.0000000000007805 10.1016/j.cellimm.2014.05.006 10.1080/00365521.2016.1233576 10.1038/srep39105 10.1111/jgh.12340 10.1002/art.40399 10.1038/nature14468 10.7314/APJCP.2012.13.8.4031 10.3109/03009742.2013.823517 |
| ContentType | Journal Article |
| Copyright | 2020 Copyright © 2020. Published by Elsevier B.V. |
| Copyright_xml | – notice: 2020 – notice: Copyright © 2020. Published by Elsevier B.V. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 DOA |
| DOI | 10.1016/j.jfma.2020.04.004 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic Directory of Open Access Journals - May need to register for free articles |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1876-0821 |
| EndPage | 59 |
| ExternalDocumentID | oai_doaj_org_article_464b5cab8b8842bbbdebf146a4b61189 32334916 10_1016_j_jfma_2020_04_004 S0929664620301248 |
| Genre | Journal Article Review |
| GroupedDBID | --- --K .1- .55 .FO .~1 0R~ 188 1B1 1P~ 1~. 1~5 2UF 2WC 4.4 457 4G. 53G 5GY 5VS 7-5 71M 8P~ 8RM AABNK AAEDW AAIKJ AALRI AAQFI AAWTL AAXUO AAYWO ABBQC ABFNM ABJNI ABMAC ABWVN ABXDB ACGFO ACRPL ACVFH ADCNI ADMUD ADNMO ADVLN AEKER AENEX AEUPX AEVXI AEXQZ AFPUW AFRHN AFTJW AGHFR AGYEJ AIGII AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ CS3 DU5 EBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FIRID FNPLU GBLVA GROUPED_DOAJ GX1 HVGLF HZ~ IHE IPNFZ J1W M41 MO0 N9A O-L O9- OK1 OZT P-8 P-9 P2P PC. Q38 RIG ROL RPZ SDF SDG SEL SES SSZ TR2 UZ5 X7M Z5R ZXP 0SF 6I. AACTN AAFTH AFCTW AHPSJ AINHJ CEFSP CNMHZ LCYCR NCXOZ AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c517t-a647e6ca1a071812e95a9fca731eca77d64b49e0e5d5023ec32d9978e1e8012d3 |
| IEDL.DBID | .~1 |
| ISSN | 0929-6646 |
| IngestDate | Wed Aug 27 01:19:32 EDT 2025 Fri Jul 11 16:17:33 EDT 2025 Mon Jul 21 06:03:50 EDT 2025 Thu Apr 24 23:06:53 EDT 2025 Tue Jul 01 03:33:51 EDT 2025 Fri Feb 23 02:45:48 EST 2024 Tue Aug 26 20:29:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 1 |
| Keywords | Genetic susceptibility Pathogenesis Pathway Rheumatic diseases Programmed death-1 |
| Language | English |
| License | This is an open access article under the CC BY-NC-ND license. Copyright © 2020. Published by Elsevier B.V. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c517t-a647e6ca1a071812e95a9fca731eca77d64b49e0e5d5023ec32d9978e1e8012d3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 ObjectType-Review-3 content type line 23 |
| OpenAccessLink | https://www.sciencedirect.com/science/article/pii/S0929664620301248 |
| PMID | 32334916 |
| PQID | 2395259518 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_464b5cab8b8842bbbdebf146a4b61189 proquest_miscellaneous_2395259518 pubmed_primary_32334916 crossref_citationtrail_10_1016_j_jfma_2020_04_004 crossref_primary_10_1016_j_jfma_2020_04_004 elsevier_sciencedirect_doi_10_1016_j_jfma_2020_04_004 elsevier_clinicalkey_doi_10_1016_j_jfma_2020_04_004 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | January 2021 2021-01-00 2021-Jan 20210101 2021-01-01 |
| PublicationDateYYYYMMDD | 2021-01-01 |
| PublicationDate_xml | – month: 01 year: 2021 text: January 2021 |
| PublicationDecade | 2020 |
| PublicationPlace | Singapore |
| PublicationPlace_xml | – name: Singapore |
| PublicationTitle | Journal of the Formosan Medical Association |
| PublicationTitleAlternate | J Formos Med Assoc |
| PublicationYear | 2021 |
| Publisher | Elsevier B.V Elsevier |
| Publisher_xml | – name: Elsevier B.V – name: Elsevier |
| References | Bertsias, Nakou, Choulaki, Raptopoulou, Papadimitraki, Goulielmos (bib35) 2010; 60 Johnson, Balko, Compton, Chalkias, Gorham, Xu (bib94) 2016; 375 Curran, Sharon (bib112) 2017; 44 Latchman, Wood, Chernova, Chaudhary, Borde, Chernova (bib13) 2001; 2 Kimura, Fukushima, Miyashita, Aoi, Jinnin, Kosaka (bib95) 2016; 107 Concepcion, Salas, Sáez, Sarvide, Ferrer, Portu (bib118) 2015; 6 Pedoeem, Azoulay-Alfaguter, Strazza, Silverman, Mor (bib11) 2014; 153 Lesterhuis, Steer, Lake (bib17) 2011; 49 Yang, Liu, Liu, Zhang, Mu (bib108) 2011; 29 Yang, Wu, Tsukamoto, Leung, Lian, Rainbow (bib119) 2011; 186 Wasén, Turkkila, Bossios, Erlandsson, Andersson, Ekerljung (bib68) 2017; 78 Sim, Park, Park, Lee (bib110) 2011; 164 Cappelli, Gutierrez, Baer, Albayda, Manno, Haque (bib69) 2017; 76 Aarslev, Dige, Greisen, Kreutzfeldt, Jessen, Vilstrup (bib22) 2017; 52 Kristjansdottir, Steinsson, Gunnarsson, Gröndal, Erlendsson, Alarcón-Riquelme (bib34) 2010; 62 Shinohara, Taniwaki, Ishida, Kawaichi, Honjo (bib5) 1994; 23 Tan, Toh, Takano (bib96) 2017; 12 Kostine, Rouxel, Barnetche, Veillon, Martin, Dutriaux (bib72) 2017; 77 Tahoori, Pourfathollah, Akhlaghi, Daneshmandi, Nicknam, Soleimanifar (bib77) 2011; 29 Nishimura, Nose, Hiai, Minato, Honjo (bib26) 1999; 11 Han, Yang, Yu, Wan, Lv, Zou (bib42) 2019; 29 Ramos-Casals, Maria, Suárez-Almazor, Lambotte, Fisher, Hernández-Molina (bib86) 2019; 37 Belkhir, Burel, Dunogeant, Marabelle, Hollebecque, Besse (bib71) 2017; 76 Fellner, Chen, Lotem, Bokstein, Taliansky, Rosenberg (bib93) 2016; 29 Rook (bib3) 2012; 42 Chen, Li, Deng, Li, Wen, Wu (bib106) 2016; 36 Gao, Gai, Wang, Liu, Liu, Wei (bib55) 2017; 8 Zhou, Xu, Hu, Xie, Lu, Zhang (bib103) 2015; 349 Chen, Peng, Yang, Yin, Shi, Zhang (bib45) 2018; 45 Hayter, Cook (bib1) 2012; 11 Mozaffarian, Wiedeman, Stevens (bib36) 2008; 47 Liao, Zheng, Wu, Zhang, Wang, Zhang (bib30) 2017; 46 Mostowska, Wudarski, Chwalinska-Sadowska, Jagodzinski (bib52) 2008; 26 Cappelli, Gutierrez, Bingham, Shah (bib7) 2017; 69 Rao, Gurish, Marshall, Slowikowski, Fonseka, Liu (bib67) 2017; 542 Hatachi, Iwai, Kawano, Morinobu, Kobayashi, Koshiba (bib66) 2003; 30 Kasagi, Kawano, Okazaki, Honjo, Morinobu, Hatachi (bib28) 2010; 184 Kao, Liao, Markovic, Klein, Naddaf, Staff (bib91) 2017; 74 Moret, van der Wurff-Jacobs, Bijlsma, Lafeber, van Roon (bib65) 2014; 16 Yanaba, Hayashi, Yoshihara, Nakagawa (bib87) 2016; 43 Kobayashi, Kawano, Hatachi, Kurimoto, Okazaki, Iwai (bib84) 2005; 32 Grant, Holder, Liberal, Heneghan, Ma, Mieli-Vergani (bib115) 2017; 189 Wan, Nie, Liu, Feng, He, Xu (bib75) 2006; 177 Elhag, Hu, Wen-Ying, Li, Yuan, Deng (bib24) 2012; 13 Liu, Weng, Weng (bib40) 2009; 2009 Dai, Jia, Zhang, Fang, Huang (bib14) 2014; 290 Ferreiros-Vidal, Gomez-Reino, Barros, Carracedo, Carreira, Gonzalez-Escribano (bib50) 2004; 50 Gandiga, Wang, Gonzalez-Rivera, Sreih (bib97) 2018; 57 McKinney, Lee, Jayne, Lyons, Smith (bib38) 2015; 523 Lin, Yen, Tsai, Tsai, Ou, Liu (bib54) 2014; 50 Zou, Zhang, Liu, Liu, Xu (bib82) 2017; 96 Leonardi, Gainor, Altan, Kravets, Dahlberg, Gedmintas (bib32) 2018; 36 Hamel, Cao, Wang, Rodeghero, Kobezda, Chen (bib61) 2010; 40 Hassel, Heinzerling, Aberle, Bähr, Eigentler, Grimm (bib33) 2017; 57 Shi, Ye, Teng, Yin, Hu, Wu (bib37) 2017; 19 Yokosuka, Takamatsu, Kobayashi-Imanishi, Hashimoto-Tane, Azuma, Saito (bib20) 2012; 209 Bommarito, Hall, Taams, Corrigall (bib73) 2017; 188 Her, Kim, Oh, Jeong, Choi (bib44) 2009; 18 Laurent, Le Fur, Le Bloas, Néel, Mary, Moreau (bib31) 2017; 47 Coronel-Restrepo, Posso-Osorio, Naranjo-Escobar, Tobón (bib2) 2017; 16 Kong, Prokunina-Olsson, Wong, Lau, Chan, Alarcón-Riquelme (bib79) 2005; 52 Raptopoulou, Bertsias, Makrygiannakis, Verginis, Kritikos, Tzardi (bib58) 2010; 62 Singla, Wenderfer, Muscal, Sagcal-Gironella, Orange, Makedonas (bib39) 2017; 5 Fukasawa, Yoshizaki, Ebata, Nakamura, Saigusa, Miura (bib25) 2017; 69 Kao, Brickshawana, Liewluck (bib92) 2018; 18 Wong, La Cava, Hahn (bib27) 2013; 190 Yang, Zou, Bai, Li (bib107) 2015; 20 Mataki, Kikuchi, Kawai, Higashiyama, Okada, Kurihara (bib113) 2007; 102 Greisen, Yan, Hansen, Venø, Nyengaard, Moestrup (bib76) 2017; 8 Prokunina, Padyukov, Bennet, de Faire, Wiman, Prince (bib80) 2004; 50 Zhao, Wang, Dong, Zhou, Cao, Yagita (bib120) 2019; 3 Dong, Zhu, Tamada, Chen (bib12) 1999; 5 Manzel, Muller, Hafler, Erdman, Linker, Kleinewietfeld (bib4) 2014; 14 Liu, Jiang, Gao, Wang, Hu, Wu (bib63) 2015; 17 Dalakas (bib102) 2004; 17 Choi, Kim, Suh, Byun, Jung, Sohn (bib109) 2015; 16 Uchio, Taira, Ikenaga, Unuma, Kadoya, Kubota (bib100) 2018; 5 Yang, Qiao, Hassan, Li, Zhang, Kong (bib59) 2016; 64 Meng, Guo, Hou, Jiang, Kijlstra, Yang (bib111) 2011; 6 Greisen, Rasmussen, Stengaard-Pedersen, Hetland, Hørslev-Petersen, Hvid (bib23) 2014; 43 do Canto, Farias, Medeiros, Coêlho, Sereia, Back (bib53) 2015; 56 Dolff, Quandt, Feldkamp, Jun, Mitchell, Hua (bib41) 2014; 43 Abelson, Johansson, Kozyrev, Kristjansdottir, Gunnarsson, Svenungsson (bib56) 2007; 8 Agata, Kawasaki, Nishimura, Ishida, Tsubat, Yagita (bib10) 1996; 8 Oikawa, Takahashi, Ishikawa, Hokari, Otsuki, Azuma (bib114) 2007; 57 Jin, Ahmed, Okazaki (bib9) 2011; 350 Suzuki, Ishikawa, Konoeda, Seki, Fukushima, Takahashi (bib101) 2017; 89 Kong, Peng, Wang, Yang, Jiang, Qi (bib49) 2008; 9 Messal, Serriari, Pastor, Nunès, Olive (bib16) 2011; 48 Velázquez-Cruz, Orozco, Espinosa-Rosales, Carreño-Manjarrez, Solís-Vallejo, López-Lara (bib51) 2007; 15 Wasen, Erlandsson, Bossios, Ekerljung, Malmhall, Toyra Silfversward (bib74) 2018; 9 Gianchecchi, Delfino, Fierabracci (bib15) 2013; 12 Hebeisen, Baitsch, Presotto, Baumgaertner, Romero, Michielin (bib18) 2013; 123 Miyake, Yamamoto, Matsushita, Abe, Takahashi, Umemura (bib116) 2014; 44 Li, Liao, Chen, Shan, Song, Zhang (bib64) 2014; 37 Sharpe, Wherry, Ahmed, Freeman (bib6) 2007; 8 Chen, Chen, Lee, Tsai, Chou (bib104) 2011; 30 Brown, Dorfman, Ma, Sullivan, Munoz, Wood (bib21) 2003; 170 Zhou, Xiong, Wang, Ding, Hu, Zhao (bib29) 2016; 162 Bourgeois-Vionnet, Joubert, Bernard, Sia, Pante, Fabien (bib99) 2018; 387 Matsumoto, Miyake, Matsushita, Ohnishi, Ikeda, Shiraha (bib117) 2014; 29 Zhou, Jin, Kawai, Yu (bib83) 2016; 6 Duan, Gui, Li, Lin, Gober, Qin (bib105) 2017; 11 Mahmoudi, Rezaiemanesh, Salmaninejad, Harsini, Poursani, Bahrami (bib47) 2015; 48 Nishimura, Honjo, Minato (bib19) 2000; 191 Prokunina, Castillejo-Lopez, Oberg, Gunnarsson, Berg, Magnusson (bib46) 2002; 32 Menzies, Johnson, Ramanujam, Atkinson, Wong, Park (bib85) 2016; 28 Vallet, Gaillet, Weiss, Vanhaecke, Saheb, Touitou (bib98) 2016; 27 Luo, Zeng, Mei, Huang, Luo, Ye (bib43) 2017; 10 Yap, Tee, Wong, Chow, Peh, Teow (bib57) 2018; 7 Good-Jacobson, Szumilas, Chen, Sharpe, Tomayko, Shlomchik (bib62) 2010; 11 Keir, Butte, Freeman, Sharpe (bib8) 2008; 26 Calabrese, Kirchner, Kontzias, Velcheti, Calabrese (bib70) 2017; 3 Iwamoto, Ikari, Inoue, Toyama, Hara, Yamanaka (bib81) 2007; 52 Fleury, Belkina, Proctor, Zammitti, Simms, Lauffenburger (bib88) 2018; 70 Liu, Jiang, Gao, Hu, Wang, Shen (bib78) 2014; 2014 Liewluck, Kao, Mauermann (bib90) 2018; 41 Chua, Lian, Sim, Cheah, Lau (bib48) 2015; 16 Arruda, Lima-Júnior, Clave, Moraes, Douay, Fournier (bib89) 2018; 53 Wang, Hu, Yang, Shen, Wu (bib60) 2011; 31 Iwamoto (10.1016/j.jfma.2020.04.004_bib81) 2007; 52 Prokunina (10.1016/j.jfma.2020.04.004_bib46) 2002; 32 Hassel (10.1016/j.jfma.2020.04.004_bib33) 2017; 57 Kimura (10.1016/j.jfma.2020.04.004_bib95) 2016; 107 Curran (10.1016/j.jfma.2020.04.004_bib112) 2017; 44 Yang (10.1016/j.jfma.2020.04.004_bib119) 2011; 186 Concepcion (10.1016/j.jfma.2020.04.004_bib118) 2015; 6 Liu (10.1016/j.jfma.2020.04.004_bib40) 2009; 2009 Miyake (10.1016/j.jfma.2020.04.004_bib116) 2014; 44 Calabrese (10.1016/j.jfma.2020.04.004_bib70) 2017; 3 Messal (10.1016/j.jfma.2020.04.004_bib16) 2011; 48 Dolff (10.1016/j.jfma.2020.04.004_bib41) 2014; 43 Hatachi (10.1016/j.jfma.2020.04.004_bib66) 2003; 30 Yang (10.1016/j.jfma.2020.04.004_bib59) 2016; 64 Li (10.1016/j.jfma.2020.04.004_bib64) 2014; 37 Manzel (10.1016/j.jfma.2020.04.004_bib4) 2014; 14 Wang (10.1016/j.jfma.2020.04.004_bib60) 2011; 31 Kao (10.1016/j.jfma.2020.04.004_bib91) 2017; 74 Greisen (10.1016/j.jfma.2020.04.004_bib23) 2014; 43 Tan (10.1016/j.jfma.2020.04.004_bib96) 2017; 12 Gao (10.1016/j.jfma.2020.04.004_bib55) 2017; 8 Yap (10.1016/j.jfma.2020.04.004_bib57) 2018; 7 Dalakas (10.1016/j.jfma.2020.04.004_bib102) 2004; 17 Fellner (10.1016/j.jfma.2020.04.004_bib93) 2016; 29 Vallet (10.1016/j.jfma.2020.04.004_bib98) 2016; 27 Wong (10.1016/j.jfma.2020.04.004_bib27) 2013; 190 Hamel (10.1016/j.jfma.2020.04.004_bib61) 2010; 40 Fukasawa (10.1016/j.jfma.2020.04.004_bib25) 2017; 69 Kostine (10.1016/j.jfma.2020.04.004_bib72) 2017; 77 Bommarito (10.1016/j.jfma.2020.04.004_bib73) 2017; 188 Suzuki (10.1016/j.jfma.2020.04.004_bib101) 2017; 89 Grant (10.1016/j.jfma.2020.04.004_bib115) 2017; 189 Mahmoudi (10.1016/j.jfma.2020.04.004_bib47) 2015; 48 Liao (10.1016/j.jfma.2020.04.004_bib30) 2017; 46 Raptopoulou (10.1016/j.jfma.2020.04.004_bib58) 2010; 62 Kristjansdottir (10.1016/j.jfma.2020.04.004_bib34) 2010; 62 Aarslev (10.1016/j.jfma.2020.04.004_bib22) 2017; 52 Good-Jacobson (10.1016/j.jfma.2020.04.004_bib62) 2010; 11 Wasen (10.1016/j.jfma.2020.04.004_bib74) 2018; 9 Mataki (10.1016/j.jfma.2020.04.004_bib113) 2007; 102 Menzies (10.1016/j.jfma.2020.04.004_bib85) 2016; 28 Chua (10.1016/j.jfma.2020.04.004_bib48) 2015; 16 Yang (10.1016/j.jfma.2020.04.004_bib108) 2011; 29 Zou (10.1016/j.jfma.2020.04.004_bib82) 2017; 96 Latchman (10.1016/j.jfma.2020.04.004_bib13) 2001; 2 Sim (10.1016/j.jfma.2020.04.004_bib110) 2011; 164 Johnson (10.1016/j.jfma.2020.04.004_bib94) 2016; 375 Gandiga (10.1016/j.jfma.2020.04.004_bib97) 2018; 57 Fleury (10.1016/j.jfma.2020.04.004_bib88) 2018; 70 Wasén (10.1016/j.jfma.2020.04.004_bib68) 2017; 78 McKinney (10.1016/j.jfma.2020.04.004_bib38) 2015; 523 Luo (10.1016/j.jfma.2020.04.004_bib43) 2017; 10 Prokunina (10.1016/j.jfma.2020.04.004_bib80) 2004; 50 Liewluck (10.1016/j.jfma.2020.04.004_bib90) 2018; 41 Nishimura (10.1016/j.jfma.2020.04.004_bib19) 2000; 191 Jin (10.1016/j.jfma.2020.04.004_bib9) 2011; 350 Arruda (10.1016/j.jfma.2020.04.004_bib89) 2018; 53 Dong (10.1016/j.jfma.2020.04.004_bib12) 1999; 5 Kasagi (10.1016/j.jfma.2020.04.004_bib28) 2010; 184 Greisen (10.1016/j.jfma.2020.04.004_bib76) 2017; 8 Moret (10.1016/j.jfma.2020.04.004_bib65) 2014; 16 Shinohara (10.1016/j.jfma.2020.04.004_bib5) 1994; 23 Kong (10.1016/j.jfma.2020.04.004_bib79) 2005; 52 Lesterhuis (10.1016/j.jfma.2020.04.004_bib17) 2011; 49 Lin (10.1016/j.jfma.2020.04.004_bib54) 2014; 50 Tahoori (10.1016/j.jfma.2020.04.004_bib77) 2011; 29 Leonardi (10.1016/j.jfma.2020.04.004_bib32) 2018; 36 Hayter (10.1016/j.jfma.2020.04.004_bib1) 2012; 11 Sharpe (10.1016/j.jfma.2020.04.004_bib6) 2007; 8 Yanaba (10.1016/j.jfma.2020.04.004_bib87) 2016; 43 Bertsias (10.1016/j.jfma.2020.04.004_bib35) 2010; 60 Keir (10.1016/j.jfma.2020.04.004_bib8) 2008; 26 Gianchecchi (10.1016/j.jfma.2020.04.004_bib15) 2013; 12 Duan (10.1016/j.jfma.2020.04.004_bib105) 2017; 11 Laurent (10.1016/j.jfma.2020.04.004_bib31) 2017; 47 Velázquez-Cruz (10.1016/j.jfma.2020.04.004_bib51) 2007; 15 Nishimura (10.1016/j.jfma.2020.04.004_bib26) 1999; 11 Mostowska (10.1016/j.jfma.2020.04.004_bib52) 2008; 26 Shi (10.1016/j.jfma.2020.04.004_bib37) 2017; 19 Coronel-Restrepo (10.1016/j.jfma.2020.04.004_bib2) 2017; 16 Kong (10.1016/j.jfma.2020.04.004_bib49) 2008; 9 Elhag (10.1016/j.jfma.2020.04.004_bib24) 2012; 13 Han (10.1016/j.jfma.2020.04.004_bib42) 2019; 29 Ferreiros-Vidal (10.1016/j.jfma.2020.04.004_bib50) 2004; 50 Liu (10.1016/j.jfma.2020.04.004_bib63) 2015; 17 Zhou (10.1016/j.jfma.2020.04.004_bib83) 2016; 6 Yokosuka (10.1016/j.jfma.2020.04.004_bib20) 2012; 209 Kao (10.1016/j.jfma.2020.04.004_bib92) 2018; 18 Cappelli (10.1016/j.jfma.2020.04.004_bib69) 2017; 76 Belkhir (10.1016/j.jfma.2020.04.004_bib71) 2017; 76 Matsumoto (10.1016/j.jfma.2020.04.004_bib117) 2014; 29 Pedoeem (10.1016/j.jfma.2020.04.004_bib11) 2014; 153 Hebeisen (10.1016/j.jfma.2020.04.004_bib18) 2013; 123 Rao (10.1016/j.jfma.2020.04.004_bib67) 2017; 542 Cappelli (10.1016/j.jfma.2020.04.004_bib7) 2017; 69 Kobayashi (10.1016/j.jfma.2020.04.004_bib84) 2005; 32 Dai (10.1016/j.jfma.2020.04.004_bib14) 2014; 290 Bourgeois-Vionnet (10.1016/j.jfma.2020.04.004_bib99) 2018; 387 Yang (10.1016/j.jfma.2020.04.004_bib107) 2015; 20 Wan (10.1016/j.jfma.2020.04.004_bib75) 2006; 177 Rook (10.1016/j.jfma.2020.04.004_bib3) 2012; 42 Singla (10.1016/j.jfma.2020.04.004_bib39) 2017; 5 Chen (10.1016/j.jfma.2020.04.004_bib104) 2011; 30 Abelson (10.1016/j.jfma.2020.04.004_bib56) 2007; 8 Zhou (10.1016/j.jfma.2020.04.004_bib103) 2015; 349 do Canto (10.1016/j.jfma.2020.04.004_bib53) 2015; 56 Mozaffarian (10.1016/j.jfma.2020.04.004_bib36) 2008; 47 Chen (10.1016/j.jfma.2020.04.004_bib45) 2018; 45 Ramos-Casals (10.1016/j.jfma.2020.04.004_bib86) 2019; 37 Oikawa (10.1016/j.jfma.2020.04.004_bib114) 2007; 57 Uchio (10.1016/j.jfma.2020.04.004_bib100) 2018; 5 Zhou (10.1016/j.jfma.2020.04.004_bib29) 2016; 162 Zhao (10.1016/j.jfma.2020.04.004_bib120) 2019; 3 Agata (10.1016/j.jfma.2020.04.004_bib10) 1996; 8 Meng (10.1016/j.jfma.2020.04.004_bib111) 2011; 6 Liu (10.1016/j.jfma.2020.04.004_bib78) 2014; 2014 Choi (10.1016/j.jfma.2020.04.004_bib109) 2015; 16 Brown (10.1016/j.jfma.2020.04.004_bib21) 2003; 170 Her (10.1016/j.jfma.2020.04.004_bib44) 2009; 18 Chen (10.1016/j.jfma.2020.04.004_bib106) 2016; 36 |
| References_xml | – volume: 36 start-page: 1905 year: 2018 end-page: 1912 ident: bib32 article-title: Safety of programmed death-1 pathway inhibitors among patients with non-small-cell lung cancer and preexisting autoimmune disorders publication-title: J Clin Oncol – volume: 3 year: 2017 ident: bib70 article-title: Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity publication-title: RMD Open – volume: 32 start-page: 666 year: 2002 end-page: 669 ident: bib46 article-title: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans publication-title: Nat Genet – volume: 74 start-page: 1216 year: 2017 end-page: 1222 ident: bib91 article-title: Neurological complications associated with anti–programmed death 1 (PD-1) antibodies publication-title: JAMA Neurol – volume: 47 start-page: 1368 year: 2017 end-page: 1376 ident: bib31 article-title: Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28 publication-title: Eur J Immunol – volume: 8 start-page: 239 year: 2007 end-page: 245 ident: bib6 article-title: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection publication-title: Nat Immunol – volume: 190 start-page: 5402 year: 2013 end-page: 5410 ident: bib27 article-title: Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease publication-title: J Immunol – volume: 3 start-page: 292 year: 2019 end-page: 305 ident: bib120 article-title: Depletion of PD-1-positive cells ameliorates autoimmune disease publication-title: Nat Biomed Eng – volume: 6 start-page: 28588 year: 2015 end-page: 28606 ident: bib118 article-title: CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis publication-title: Oncotarget – volume: 45 start-page: 835 year: 2018 end-page: 840 ident: bib45 article-title: Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis publication-title: J Rheumatol – volume: 78 start-page: 101 year: 2017 end-page: 110 ident: bib68 article-title: Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis publication-title: J Autoimmun – volume: 49 start-page: 1 year: 2011 end-page: 3 ident: bib17 article-title: PD-L2 is predominantly expressed by Th2 cells publication-title: Mol Immunol – volume: 188 start-page: 455 year: 2017 end-page: 466 ident: bib73 article-title: Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1 publication-title: Clin Exp Immunol – volume: 17 start-page: 561 year: 2004 end-page: 567 ident: bib102 article-title: Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis publication-title: Curr Opin Neurol – volume: 191 start-page: 891 year: 2000 end-page: 898 ident: bib19 article-title: Facilitation of β selection and modification of positive selection in the thymus of Pd-1–deficient mice publication-title: J Exp Med – volume: 62 start-page: 1702 year: 2010 end-page: 1711 ident: bib34 article-title: Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 11 start-page: 754 year: 2012 end-page: 765 ident: bib1 article-title: Updated assessment of the prevalence, spectrum and case definition of autoimmune disease publication-title: Autoimmun Rev – volume: 8 start-page: 765 year: 1996 end-page: 772 ident: bib10 article-title: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes publication-title: Int Immunol – volume: 16 start-page: 7413 year: 2015 end-page: 7427 ident: bib109 article-title: The relevance of miRNA-21 in HSV-induced inflammation in a mouse model publication-title: Int J Mol Sci – volume: 27 start-page: 1352 year: 2016 end-page: 1353 ident: bib98 article-title: Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma publication-title: Ann Oncol – volume: 107 start-page: 1055 year: 2016 end-page: 1058 ident: bib95 article-title: Myasthenic crisis and polymyositis induced by one dose of nivolumab publication-title: Canc Sci – volume: 5 start-page: 1 year: 2017 end-page: 8 ident: bib39 article-title: Changes in frequency and activation status of major CD4(+) T-cell subsets after initiation of immunosuppressive therapy in a patient with new diagnosis childhood-onset systemic lupus erythematosus publication-title: Front Pediatr – volume: 170 start-page: 1257 year: 2003 end-page: 1266 ident: bib21 article-title: Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production publication-title: J Immunol – volume: 46 start-page: 371 year: 2017 end-page: 379 ident: bib30 article-title: The systemic activation of programmed death 1-PD-L1 axis protects systemic lupus erythematosus model from nephritis publication-title: Am J Nephrol – volume: 28 start-page: 368 year: 2016 end-page: 376 ident: bib85 article-title: Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab publication-title: Ann Oncol – volume: 62 start-page: 1870 year: 2010 end-page: 1880 ident: bib58 article-title: The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis publication-title: Arthritis Rheum – volume: 57 start-page: 485 year: 2007 end-page: 492 ident: bib114 article-title: Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease publication-title: Pathol Int – volume: 16 start-page: 9794 year: 2015 end-page: 9803 ident: bib48 article-title: Association between PDCD1 gene polymorphisms and risk of systemic lupus erythematosus in three main ethnic groups of the Malaysian population publication-title: Int J Mol Sci – volume: 70 start-page: 566 year: 2018 end-page: 577 ident: bib88 article-title: Increased expression and modulated regulatory activity of coinhibitory receptors PD-1, TIGIT, and TIM-3 in lymphocytes from patients with systemic sclerosis publication-title: Arthritis Rheum – volume: 32 start-page: 2156 year: 2005 end-page: 2163 ident: bib84 article-title: Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome publication-title: J Rheumatol – volume: 96 year: 2017 ident: bib82 article-title: Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis? publication-title: Medicine – volume: 89 start-page: 1127 year: 2017 end-page: 1134 ident: bib101 article-title: Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan publication-title: Neurology – volume: 50 start-page: 2590 year: 2004 end-page: 2597 ident: bib50 article-title: Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects publication-title: Arthritis Rheum – volume: 8 start-page: 36885 year: 2017 end-page: 36897 ident: bib55 article-title: Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk publication-title: Oncotarget – volume: 8 start-page: 1 year: 2017 end-page: 14 ident: bib76 article-title: Extracellular vesicles transfer the receptor programmed death-1 in rheumatoid arthritis publication-title: Front Immunol – volume: 18 start-page: 1 year: 2018 end-page: 9 ident: bib92 article-title: Neuromuscular complications of programmed cell death-1 (PD-1) inhibitors publication-title: Curr Neurol Neurosci Rep – volume: 2009 start-page: 406136 year: 2009 ident: bib40 article-title: Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus publication-title: J Biomed Biotechnol – volume: 52 start-page: 93 year: 2017 end-page: 99 ident: bib22 article-title: Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis publication-title: Scand J Gastroenterol – volume: 15 start-page: 336 year: 2007 end-page: 341 ident: bib51 article-title: Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus publication-title: Eur J Hum Genet – volume: 26 start-page: 457 year: 2008 end-page: 460 ident: bib52 article-title: The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population publication-title: Clin Exp Rheumatol – volume: 10 start-page: 7716 year: 2017 end-page: 7724 ident: bib43 article-title: PD-L1-expressing neutrophils as a novel indicator to assess disease activity of rheumatoid arthritis publication-title: Int J Clin Exp Med – volume: 13 start-page: 4031 year: 2012 end-page: 4036 ident: bib24 article-title: Reconstructed adeno-associated virus with the extracellular domain of murine PD-1 induces antitumor immunity publication-title: Asian Pac J Cancer Prev APJCP – volume: 350 start-page: 17 year: 2011 end-page: 37 ident: bib9 article-title: Role of PD-1 in regulating T-cell immunity publication-title: Curr Top Microbiol Immunol – volume: 47 start-page: 1335 year: 2008 end-page: 1341 ident: bib36 article-title: Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1 publication-title: Rheumatology – volume: 2 start-page: 261 year: 2001 end-page: 268 ident: bib13 article-title: PD-L2 is a second ligand for PD-1 and inhibits T cell activation publication-title: Nat Immunol – volume: 30 start-page: 1410 year: 2003 end-page: 1419 ident: bib66 article-title: CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid publication-title: J Rheumatol – volume: 16 start-page: 497 year: 2014 ident: bib65 article-title: Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions publication-title: Arthritis Res Ther – volume: 52 start-page: 557 year: 2007 end-page: 560 ident: bib81 article-title: Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population publication-title: J Hum Genet – volume: 44 start-page: 1299 year: 2014 end-page: 1307 ident: bib116 article-title: Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis publication-title: Hepatol Res – volume: 17 start-page: 1 year: 2015 end-page: 13 ident: bib63 article-title: Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways publication-title: Arthritis Res Ther – volume: 50 start-page: 1770 year: 2004 end-page: 1773 ident: bib80 article-title: Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope publication-title: Arthritis Rheum – volume: 5 start-page: e464 year: 2018 ident: bib100 article-title: Granulomatous myositis induced by anti–PD-1 monoclonal antibodies publication-title: Neurology – volume: 76 start-page: 1747 year: 2017 end-page: 1750 ident: bib71 article-title: Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment publication-title: Ann Rheum Dis – volume: 26 start-page: 677 year: 2008 end-page: 704 ident: bib8 article-title: PD-1 and its ligands in tolerance and immunity publication-title: Annu Rev Immunol – volume: 162 start-page: 1 year: 2016 end-page: 8 ident: bib29 article-title: Treatment of murine lupus with PD-LIg publication-title: Clin Immunol – volume: 290 start-page: 72 year: 2014 end-page: 79 ident: bib14 article-title: The PD-1/PD-Ls pathway and autoimmune diseases publication-title: Cell Immunol – volume: 29 start-page: 110 year: 2014 end-page: 115 ident: bib117 article-title: Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis publication-title: J Gastroenterol Hepatol – volume: 69 start-page: 1751 year: 2017 end-page: 1763 ident: bib7 article-title: Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature publication-title: Arthritis Care Res (Hoboken) – volume: 542 start-page: 110 year: 2017 end-page: 114 ident: bib67 article-title: Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis publication-title: Nature – volume: 77 start-page: 393 year: 2017 end-page: 398 ident: bib72 article-title: Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study publication-title: Ann Rheum Dis – volume: 186 start-page: 1259 year: 2011 end-page: 1267 ident: bib119 article-title: CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease publication-title: J Immunol – volume: 43 start-page: 954 year: 2016 end-page: 957 ident: bib87 article-title: Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: association with extent of skin sclerosis publication-title: J Dermatol – volume: 30 start-page: 1181 year: 2011 end-page: 1187 ident: bib104 article-title: Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis publication-title: Clin Rheumatol – volume: 56 start-page: 483 year: 2015 end-page: 489 ident: bib53 article-title: Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility publication-title: Rev Bras Reumatol – volume: 29 start-page: 763 year: 2011 end-page: 767 ident: bib77 article-title: Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients publication-title: Clin Exp Rheumatol – volume: 7 start-page: 161 year: 2018 ident: bib57 article-title: Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development publication-title: Cells – volume: 41 start-page: 208 year: 2018 end-page: 211 ident: bib90 article-title: PD-1 inhibitor-associated myopathies publication-title: J Immunother – volume: 12 start-page: 1091 year: 2013 end-page: 1100 ident: bib15 article-title: Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity publication-title: Autoimmun Rev – volume: 69 start-page: 1879 year: 2017 end-page: 1890 ident: bib25 article-title: Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis publication-title: Arthritis Rheum – volume: 31 start-page: 513 year: 2011 end-page: 519 ident: bib60 article-title: The effects of PDL-Ig on collagen-induced arthritis publication-title: Rheumatol Int – volume: 9 start-page: 321 year: 2008 end-page: 324 ident: bib49 article-title: Association study of PDCD1 and CD22 polymorphisms with the development of systemic lupus erythematosus in Southern Chinese Han people publication-title: Chin Prev Med – volume: 14 start-page: 404 year: 2014 ident: bib4 article-title: Role of "Western diet" in inflammatory autoimmune diseases publication-title: Curr Allergy Asthma Rep – volume: 523 start-page: 612 year: 2015 end-page: 616 ident: bib38 article-title: T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection publication-title: Nature – volume: 153 start-page: 145 year: 2014 end-page: 152 ident: bib11 article-title: Programmed death-1 pathway in cancer and autoimmunity publication-title: Clin Immunol – volume: 209 start-page: 1201 year: 2012 end-page: 1217 ident: bib20 article-title: Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 publication-title: J Exp Med – volume: 29 start-page: 13 year: 2011 end-page: 18 ident: bib108 article-title: Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population publication-title: Clin Exp Rheumatol – volume: 12 start-page: e90 year: 2017 end-page: e91 ident: bib96 article-title: Continued response to one dose of nivolumab complicated by myasthenic crisis and myositis publication-title: J Thorac Oncol – volume: 29 start-page: 461 year: 2019 end-page: 469 ident: bib42 article-title: Associations of circulating CXCR3(-)PD-1(+)CD4(+)T cells with disease activity of systemic lupus erythematosus publication-title: Mod Rheumatol – volume: 9 start-page: 1677 year: 2018 ident: bib74 article-title: Smoking is associated with low levels of soluble PD-L1 in rheumatoid arthritis publication-title: Front Immunol – volume: 16 start-page: 684 year: 2017 end-page: 692 ident: bib2 article-title: Autoimmune diseases and their relation with immunological, neurological and endocrinological axes publication-title: Autoimmun Rev – volume: 42 start-page: 5 year: 2012 end-page: 15 ident: bib3 article-title: Hygiene hypothesis and autoimmune diseases publication-title: Clin Rev Allergy Immunol – volume: 189 start-page: 71 year: 2017 end-page: 82 ident: bib115 article-title: Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis publication-title: Clin Exp Immunol – volume: 76 start-page: 43 year: 2017 end-page: 50 ident: bib69 article-title: Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab publication-title: Ann Rheum Dis – volume: 37 start-page: 114 year: 2019 end-page: 122 ident: bib86 article-title: Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International immunocancer registry (ICIR) publication-title: Clin Exp Rheumatol – volume: 37 start-page: 116 year: 2014 end-page: 121 ident: bib64 article-title: Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis publication-title: Inflammation – volume: 5 start-page: 1365 year: 1999 end-page: 1369 ident: bib12 article-title: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion publication-title: Nat Med – volume: 48 start-page: 2214 year: 2011 end-page: 2219 ident: bib16 article-title: PD-L2 is expressed on activated human T cells and regulates their function publication-title: Mol Immunol – volume: 20 start-page: 55 year: 2015 end-page: 63 ident: bib107 article-title: The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis publication-title: J Orthop Sci – volume: 123 start-page: 1044 year: 2013 end-page: 1056 ident: bib18 article-title: SHP-1 phosphatase activity counteracts increased T cell receptor affinity publication-title: J Clin Invest – volume: 36 start-page: 33 year: 2016 end-page: 44 ident: bib106 article-title: The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review publication-title: Rheumatol Int – volume: 64 start-page: 417 year: 2016 end-page: 423 ident: bib59 article-title: Program death-1 suppresses autoimmune arthritis by inhibiting Th17 response publication-title: Arch Immunol Ther Exp – volume: 387 start-page: 51 year: 2018 end-page: 53 ident: bib99 article-title: Nivolumab-induced myositis: a case report and a literature review publication-title: J Neurol Sci – volume: 57 start-page: 397 year: 2018 end-page: 398 ident: bib97 article-title: Pembrolizumab-associated inflammatory myopathy publication-title: Rheumatology – volume: 53 start-page: 1319 year: 2018 end-page: 1327 ident: bib89 article-title: Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis publication-title: Bone Marrow Transplant – volume: 23 start-page: 704 year: 1994 end-page: 706 ident: bib5 article-title: Structure and chromosomal localization of the human PD-1 gene (PDCD1) publication-title: Genomics – volume: 57 start-page: 36 year: 2017 end-page: 49 ident: bib33 article-title: Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions publication-title: Canc Treat Rev – volume: 29 start-page: 1 year: 2016 end-page: 9 ident: bib93 article-title: Neurologic complications of immune checkpoint inhibitors publication-title: J Neuro Oncol – volume: 375 start-page: 1749 year: 2016 end-page: 1755 ident: bib94 article-title: Fulminant myocarditis with combination immune checkpoint blockade publication-title: N Engl J Med – volume: 8 start-page: 69 year: 2007 end-page: 74 ident: bib56 article-title: No evidence of association between genetic variants of the PDCD1 ligands and SLE publication-title: Gene Immun – volume: 44 start-page: 428 year: 2017 end-page: 432 ident: bib112 article-title: PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma publication-title: Semin Oncol – volume: 43 start-page: 101 year: 2014 end-page: 108 ident: bib23 article-title: Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis publication-title: Scand J Rheumatol – volume: 11 start-page: 535 year: 2010 end-page: 542 ident: bib62 article-title: PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells publication-title: Nat Immunol – volume: 6 start-page: 1 year: 2016 end-page: 12 ident: bib83 article-title: Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren’s syndrome in non-obese diabetic mice publication-title: Sci Rep – volume: 48 start-page: 488 year: 2015 end-page: 493 ident: bib47 article-title: PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus publication-title: Autoimmunity – volume: 11 start-page: 69 year: 2017 end-page: 76 ident: bib105 article-title: The immune dysfunction in ankylosing spondylitis patients publication-title: Biosci Trends – volume: 19 start-page: 1 year: 2017 end-page: 10 ident: bib37 article-title: Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus mcmc erythematosus patients publication-title: Arthritis Res Ther – volume: 349 start-page: 488 year: 2015 end-page: 492 ident: bib103 article-title: Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis publication-title: Am J Med Sci – volume: 43 start-page: 307 year: 2014 end-page: 313 ident: bib41 article-title: Increased percentages of PD-1 on CD4+T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus publication-title: Scand J Rheumatol – volume: 177 start-page: 8844 year: 2006 end-page: 8850 ident: bib75 article-title: Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis publication-title: J Immunol – volume: 11 start-page: 141 year: 1999 end-page: 151 ident: bib26 article-title: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor publication-title: Immunity – volume: 52 start-page: 1058 year: 2005 end-page: 1062 ident: bib79 article-title: A new haplotype of PDCD1is associated with rheumatoid arthritis in Hong Kong Chinese publication-title: Arthritis Rheum – volume: 40 start-page: 3117 year: 2010 end-page: 3127 ident: bib61 article-title: B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis publication-title: Eur J Immunol – volume: 50 start-page: 770 year: 2014 end-page: 775 ident: bib54 article-title: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 164 start-page: 1285 year: 2011 end-page: 1291 ident: bib110 article-title: Altered expression of costimulatory molecules in Behçet's disease according to clinical activity publication-title: Br J Dermatol – volume: 6 year: 2011 ident: bib111 article-title: Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population publication-title: PloS One – volume: 102 start-page: 302 year: 2007 end-page: 312 ident: bib113 article-title: Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases publication-title: Am J Gastroenterol – volume: 60 start-page: 207 year: 2010 end-page: 218 ident: bib35 article-title: Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus publication-title: Arthritis Rheum – volume: 18 start-page: 501 year: 2009 end-page: 507 ident: bib44 article-title: Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus publication-title: Lupus – volume: 184 start-page: 2337 year: 2010 end-page: 2347 ident: bib28 article-title: Anti-programmed cell death 1 antibody reduces CD4 + PD-1 + T cells and relieves the lupus-like nephritis of NZB/W F1 mice publication-title: J Immunol – volume: 2014 start-page: 247637 year: 2014 ident: bib78 article-title: A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China publication-title: Int J Genom – volume: 11 start-page: 535 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib62 article-title: PD-1 regulates germinal center B cell survival and the formation and affinity of long-lived plasma cells publication-title: Nat Immunol doi: 10.1038/ni.1877 – volume: 16 start-page: 497 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib65 article-title: Synovial T cell hyporesponsiveness to myeloid dendritic cells is reversed by preventing PD-1/PD-L1 interactions publication-title: Arthritis Res Ther doi: 10.1186/s13075-014-0497-x – volume: 387 start-page: 51 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib99 article-title: Nivolumab-induced myositis: a case report and a literature review publication-title: J Neurol Sci doi: 10.1016/j.jns.2018.01.030 – volume: 57 start-page: 36 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib33 article-title: Combined immune checkpoint blockade (anti-PD-1/anti-CTLA-4): evaluation and management of adverse drug reactions publication-title: Canc Treat Rev doi: 10.1016/j.ctrv.2017.05.003 – volume: 37 start-page: 114 issue: Suppl 118 year: 2019 ident: 10.1016/j.jfma.2020.04.004_bib86 article-title: Sicca/Sjögren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International immunocancer registry (ICIR) publication-title: Clin Exp Rheumatol – volume: 89 start-page: 1127 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib101 article-title: Nivolumab-related myasthenia gravis with myositis and myocarditis in Japan publication-title: Neurology doi: 10.1212/WNL.0000000000004359 – volume: 30 start-page: 1410 year: 2003 ident: 10.1016/j.jfma.2020.04.004_bib66 article-title: CD4+ PD-1+ T cells accumulate as unique anergic cells in rheumatoid arthritis synovial fluid publication-title: J Rheumatol – volume: 62 start-page: 1870 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib58 article-title: The programmed death 1/programmed death ligand 1 inhibitory pathway is up-regulated in rheumatoid synovium and regulates peripheral T cell responses in human and murine arthritis publication-title: Arthritis Rheum doi: 10.1002/art.27500 – volume: 76 start-page: 43 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib69 article-title: Inflammatory arthritis and sicca syndrome induced by nivolumab and ipilimumab publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2016-209595 – volume: 26 start-page: 457 year: 2008 ident: 10.1016/j.jfma.2020.04.004_bib52 article-title: The programmed cell death 1 gene 7209 C>T polymorphism is associated with the risk of systemic lupus erythematosus in the Polish population publication-title: Clin Exp Rheumatol – volume: 11 start-page: 141 year: 1999 ident: 10.1016/j.jfma.2020.04.004_bib26 article-title: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor publication-title: Immunity doi: 10.1016/S1074-7613(00)80089-8 – volume: 102 start-page: 302 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib113 article-title: Expression of PD-1, PD-L1, and PD-L2 in the liver in autoimmune liver diseases publication-title: Am J Gastroenterol doi: 10.1111/j.1572-0241.2006.00948.x – volume: 32 start-page: 666 year: 2002 ident: 10.1016/j.jfma.2020.04.004_bib46 article-title: A regulatory polymorphism in PDCD1 is associated with susceptibility to systemic lupus erythematosus in humans publication-title: Nat Genet doi: 10.1038/ng1020 – volume: 5 start-page: e464 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib100 article-title: Granulomatous myositis induced by anti–PD-1 monoclonal antibodies publication-title: Neurology – volume: 8 start-page: 1 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib76 article-title: Extracellular vesicles transfer the receptor programmed death-1 in rheumatoid arthritis publication-title: Front Immunol doi: 10.3389/fimmu.2017.00851 – volume: 29 start-page: 13 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib108 article-title: Association of polymorphisms in the programmed cell death 1 (PD-1) and PD-1 ligand genes with ankylosing spondylitis in a Chinese population publication-title: Clin Exp Rheumatol – volume: 69 start-page: 1751 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib7 article-title: Rheumatic and musculoskeletal immune-related adverse events due to immune checkpoint inhibitors: a systematic review of the literature publication-title: Arthritis Care Res (Hoboken) doi: 10.1002/acr.23177 – volume: 191 start-page: 891 year: 2000 ident: 10.1016/j.jfma.2020.04.004_bib19 article-title: Facilitation of β selection and modification of positive selection in the thymus of Pd-1–deficient mice publication-title: J Exp Med doi: 10.1084/jem.191.5.891 – volume: 43 start-page: 954 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib87 article-title: Serum levels of soluble programmed death-1 and programmed death ligand-1 in systemic sclerosis: association with extent of skin sclerosis publication-title: J Dermatol doi: 10.1111/1346-8138.13339 – volume: 11 start-page: 69 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib105 article-title: The immune dysfunction in ankylosing spondylitis patients publication-title: Biosci Trends doi: 10.5582/bst.2016.01171 – volume: 37 start-page: 116 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib64 article-title: Expression of programmed death-1 (PD-1) on CD4+ and CD8+ T cells in rheumatoid arthritis publication-title: Inflammation doi: 10.1007/s10753-013-9718-8 – volume: 8 start-page: 765 year: 1996 ident: 10.1016/j.jfma.2020.04.004_bib10 article-title: Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes publication-title: Int Immunol doi: 10.1093/intimm/8.5.765 – volume: 9 start-page: 321 year: 2008 ident: 10.1016/j.jfma.2020.04.004_bib49 article-title: Association study of PDCD1 and CD22 polymorphisms with the development of systemic lupus erythematosus in Southern Chinese Han people publication-title: Chin Prev Med – volume: 3 start-page: 292 year: 2019 ident: 10.1016/j.jfma.2020.04.004_bib120 article-title: Depletion of PD-1-positive cells ameliorates autoimmune disease publication-title: Nat Biomed Eng doi: 10.1038/s41551-019-0360-0 – volume: 209 start-page: 1201 year: 2012 ident: 10.1016/j.jfma.2020.04.004_bib20 article-title: Programmed cell death 1 forms negative costimulatory microclusters that directly inhibit T cell receptor signaling by recruiting phosphatase SHP2 publication-title: J Exp Med doi: 10.1084/jem.20112741 – volume: 32 start-page: 2156 year: 2005 ident: 10.1016/j.jfma.2020.04.004_bib84 article-title: Enhanced expression of programmed death-1 (PD-1)/PD-L1 in salivary glands of patients with Sjogren's syndrome publication-title: J Rheumatol – volume: 56 start-page: 483 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib53 article-title: Association of PDCD1 polymorphism to systemic lupus erythematosus and rheumatoid arthritis susceptibility publication-title: Rev Bras Reumatol – volume: 57 start-page: 397 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib97 article-title: Pembrolizumab-associated inflammatory myopathy publication-title: Rheumatology doi: 10.1093/rheumatology/kex346 – volume: 2014 start-page: 247637 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib78 article-title: A promoter region polymorphism in PDCD-1 gene is associated with risk of rheumatoid arthritis in the Han Chinese population of Southeastern China publication-title: Int J Genom – volume: 77 start-page: 393 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib72 article-title: Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer—clinical aspects and relationship with tumour response: a single-centre prospective cohort study publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-212257 – volume: 5 start-page: 1365 year: 1999 ident: 10.1016/j.jfma.2020.04.004_bib12 article-title: B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion publication-title: Nat Med doi: 10.1038/70932 – volume: 36 start-page: 1905 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib32 article-title: Safety of programmed death-1 pathway inhibitors among patients with non-small-cell lung cancer and preexisting autoimmune disorders publication-title: J Clin Oncol doi: 10.1200/JCO.2017.77.0305 – volume: 11 start-page: 754 year: 2012 ident: 10.1016/j.jfma.2020.04.004_bib1 article-title: Updated assessment of the prevalence, spectrum and case definition of autoimmune disease publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2012.02.001 – volume: 349 start-page: 488 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib103 article-title: Decreased programmed death-1 expression on the T cells of patients with ankylosing spondylitis publication-title: Am J Med Sci doi: 10.1097/MAJ.0000000000000468 – volume: 76 start-page: 1747 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib71 article-title: Rheumatoid arthritis and polymyalgia rheumatica occurring after immune checkpoint inhibitor treatment publication-title: Ann Rheum Dis doi: 10.1136/annrheumdis-2017-211216 – volume: 164 start-page: 1285 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib110 article-title: Altered expression of costimulatory molecules in Behçet's disease according to clinical activity publication-title: Br J Dermatol doi: 10.1111/j.1365-2133.2011.10274.x – volume: 8 start-page: 36885 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib55 article-title: Meta-analysis of programmed cell death 1 polymorphisms with systemic lupus erythematosus risk publication-title: Oncotarget doi: 10.18632/oncotarget.16378 – volume: 17 start-page: 1 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib63 article-title: Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways publication-title: Arthritis Res Ther doi: 10.1186/s13075-015-0859-z – volume: 16 start-page: 7413 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib109 article-title: The relevance of miRNA-21 in HSV-induced inflammation in a mouse model publication-title: Int J Mol Sci doi: 10.3390/ijms16047413 – volume: 5 start-page: 1 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib39 article-title: Changes in frequency and activation status of major CD4(+) T-cell subsets after initiation of immunosuppressive therapy in a patient with new diagnosis childhood-onset systemic lupus erythematosus publication-title: Front Pediatr doi: 10.3389/fped.2017.00104 – volume: 60 start-page: 207 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib35 article-title: Genetic, immunologic, and immunohistochemical analysis of the programmed death 1/programmed death ligand 1 pathway in human systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.24227 – volume: 162 start-page: 1 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib29 article-title: Treatment of murine lupus with PD-LIg publication-title: Clin Immunol doi: 10.1016/j.clim.2015.10.006 – volume: 53 start-page: 1319 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib89 article-title: Homeostatic proliferation leads to telomere attrition and increased PD-1 expression after autologous hematopoietic SCT for systemic sclerosis publication-title: Bone Marrow Transplant doi: 10.1038/s41409-018-0162-0 – volume: 74 start-page: 1216 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib91 article-title: Neurological complications associated with anti–programmed death 1 (PD-1) antibodies publication-title: JAMA Neurol doi: 10.1001/jamaneurol.2017.1912 – volume: 14 start-page: 404 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib4 article-title: Role of "Western diet" in inflammatory autoimmune diseases publication-title: Curr Allergy Asthma Rep doi: 10.1007/s11882-013-0404-6 – volume: 47 start-page: 1368 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib31 article-title: Prevention of lupus nephritis development in NZB/NZW mice by selective blockade of CD28 publication-title: Eur J Immunol doi: 10.1002/eji.201746923 – volume: 107 start-page: 1055 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib95 article-title: Myasthenic crisis and polymyositis induced by one dose of nivolumab publication-title: Canc Sci doi: 10.1111/cas.12961 – volume: 31 start-page: 513 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib60 article-title: The effects of PDL-Ig on collagen-induced arthritis publication-title: Rheumatol Int doi: 10.1007/s00296-009-1249-0 – volume: 40 start-page: 3117 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib61 article-title: B7-H1 expression on non-B and non-T cells promotes distinct effects on T- and B-cell responses in autoimmune arthritis publication-title: Eur J Immunol doi: 10.1002/eji.201040690 – volume: 29 start-page: 763 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib77 article-title: Association of programmed cell death-1 (PDCD-1) gene polymorphisms with rheumatoid arthritis in Iranian patients publication-title: Clin Exp Rheumatol – volume: 42 start-page: 5 year: 2012 ident: 10.1016/j.jfma.2020.04.004_bib3 article-title: Hygiene hypothesis and autoimmune diseases publication-title: Clin Rev Allergy Immunol doi: 10.1007/s12016-011-8285-8 – volume: 184 start-page: 2337 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib28 article-title: Anti-programmed cell death 1 antibody reduces CD4 + PD-1 + T cells and relieves the lupus-like nephritis of NZB/W F1 mice publication-title: J Immunol doi: 10.4049/jimmunol.0901652 – volume: 23 start-page: 704 year: 1994 ident: 10.1016/j.jfma.2020.04.004_bib5 article-title: Structure and chromosomal localization of the human PD-1 gene (PDCD1) publication-title: Genomics doi: 10.1006/geno.1994.1562 – volume: 16 start-page: 9794 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib48 article-title: Association between PDCD1 gene polymorphisms and risk of systemic lupus erythematosus in three main ethnic groups of the Malaysian population publication-title: Int J Mol Sci doi: 10.3390/ijms16059794 – volume: 8 start-page: 239 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib6 article-title: The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection publication-title: Nat Immunol doi: 10.1038/ni1443 – volume: 9 start-page: 1677 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib74 article-title: Smoking is associated with low levels of soluble PD-L1 in rheumatoid arthritis publication-title: Front Immunol doi: 10.3389/fimmu.2018.01677 – volume: 64 start-page: 417 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib59 article-title: Program death-1 suppresses autoimmune arthritis by inhibiting Th17 response publication-title: Arch Immunol Ther Exp doi: 10.1007/s00005-016-0404-z – volume: 45 start-page: 835 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib45 article-title: Increased levels of soluble programmed death ligand 1 associate with malignancy in patients with dermatomyositis publication-title: J Rheumatol doi: 10.3899/jrheum.170544 – volume: 29 start-page: 461 year: 2019 ident: 10.1016/j.jfma.2020.04.004_bib42 article-title: Associations of circulating CXCR3(-)PD-1(+)CD4(+)T cells with disease activity of systemic lupus erythematosus publication-title: Mod Rheumatol doi: 10.1080/14397595.2018.1469581 – volume: 44 start-page: 428 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib112 article-title: PD-1 immunobiology in autoimmune hepatitis and hepatocellular carcinoma publication-title: Semin Oncol doi: 10.1053/j.seminoncol.2017.12.001 – volume: 47 start-page: 1335 year: 2008 ident: 10.1016/j.jfma.2020.04.004_bib36 article-title: Active systemic lupus erythematosus is associated with failure of antigen-presenting cells to express programmed death ligand-1 publication-title: Rheumatology doi: 10.1093/rheumatology/ken256 – volume: 18 start-page: 501 year: 2009 ident: 10.1016/j.jfma.2020.04.004_bib44 article-title: Increased expression of soluble inducible costimulator ligand (ICOSL) in patients with systemic lupus erythematosus publication-title: Lupus doi: 10.1177/0961203308099176 – volume: 50 start-page: 2590 year: 2004 ident: 10.1016/j.jfma.2020.04.004_bib50 article-title: Association of PDCD1 with susceptibility to systemic lupus erythematosus: evidence of population-specific effects publication-title: Arthritis Rheum doi: 10.1002/art.20436 – volume: 186 start-page: 1259 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib119 article-title: CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease publication-title: J Immunol doi: 10.4049/jimmunol.1001597 – volume: 2009 start-page: 406136 year: 2009 ident: 10.1016/j.jfma.2020.04.004_bib40 article-title: Variable increased expression of program death-1 and program death-1 ligands on peripheral mononuclear cells is not impaired in patients with systemic lupus erythematosus publication-title: J Biomed Biotechnol doi: 10.1155/2009/406136 – volume: 28 start-page: 368 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib85 article-title: Anti-PD-1 therapy in patients with advanced melanoma and preexisting autoimmune disorders or major toxicity with ipilimumab publication-title: Ann Oncol doi: 10.1093/annonc/mdw443 – volume: 17 start-page: 561 year: 2004 ident: 10.1016/j.jfma.2020.04.004_bib102 article-title: Inflammatory disorders of muscle: progress in polymyositis, dermatomyositis and inclusion body myositis publication-title: Curr Opin Neurol doi: 10.1097/00019052-200410000-00006 – volume: 57 start-page: 485 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib114 article-title: Intrahepatic expression of the co-stimulatory molecules programmed death-1, and its ligands in autoimmune liver disease publication-title: Pathol Int doi: 10.1111/j.1440-1827.2007.02129.x – volume: 177 start-page: 8844 year: 2006 ident: 10.1016/j.jfma.2020.04.004_bib75 article-title: Aberrant regulation of synovial T cell activation by soluble costimulatory molecules in rheumatoid arthritis publication-title: J Immunol doi: 10.4049/jimmunol.177.12.8844 – volume: 16 start-page: 684 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib2 article-title: Autoimmune diseases and their relation with immunological, neurological and endocrinological axes publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2017.05.002 – volume: 41 start-page: 208 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib90 article-title: PD-1 inhibitor-associated myopathies publication-title: J Immunother doi: 10.1097/CJI.0000000000000196 – volume: 123 start-page: 1044 year: 2013 ident: 10.1016/j.jfma.2020.04.004_bib18 article-title: SHP-1 phosphatase activity counteracts increased T cell receptor affinity publication-title: J Clin Invest doi: 10.1172/JCI65325 – volume: 27 start-page: 1352 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib98 article-title: Pembrolizumab-induced necrotic myositis in a patient with metastatic melanoma publication-title: Ann Oncol doi: 10.1093/annonc/mdw126 – volume: 15 start-page: 336 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib51 article-title: Association of PDCD1 polymorphisms with childhood-onset systemic lupus erythematosus publication-title: Eur J Hum Genet doi: 10.1038/sj.ejhg.5201767 – volume: 8 start-page: 69 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib56 article-title: No evidence of association between genetic variants of the PDCD1 ligands and SLE publication-title: Gene Immun doi: 10.1038/sj.gene.6364360 – volume: 189 start-page: 71 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib115 article-title: Immunosuppressive drugs affect interferon (IFN)-γ and programmed cell death 1 (PD-1) kinetics in patients with newly diagnosed autoimmune hepatitis publication-title: Clin Exp Immunol doi: 10.1111/cei.12956 – volume: 12 start-page: 1091 year: 2013 ident: 10.1016/j.jfma.2020.04.004_bib15 article-title: Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity publication-title: Autoimmun Rev doi: 10.1016/j.autrev.2013.05.003 – volume: 36 start-page: 33 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib106 article-title: The associations between PD-1, CTLA-4 gene polymorphisms and susceptibility to ankylosing spondylitis: a meta-analysis and systemic review publication-title: Rheumatol Int doi: 10.1007/s00296-015-3327-9 – volume: 6 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib111 article-title: Lack of an association of PD-1 and its ligand genes with Behcet's disease in a Chinese Han population publication-title: PloS One doi: 10.1371/journal.pone.0025345 – volume: 20 start-page: 55 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib107 article-title: The programmed cell death 1 gene polymorphisms (PD 1.3 G/A, PD 1.5 C/T and PD 1.9 C/T) and susceptibility to ankylosing spondylitis: a meta-analysis publication-title: J Orthop Sci doi: 10.1007/s00776-014-0648-6 – volume: 12 start-page: e90 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib96 article-title: Continued response to one dose of nivolumab complicated by myasthenic crisis and myositis publication-title: J Thorac Oncol doi: 10.1016/j.jtho.2017.02.024 – volume: 6 start-page: 28588 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib118 article-title: CD8+ T cells undergo activation and programmed death-1 repression in the liver of aged Ae2a,b-/- mice favoring autoimmune cholangitis publication-title: Oncotarget doi: 10.18632/oncotarget.5665 – volume: 350 start-page: 17 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib9 article-title: Role of PD-1 in regulating T-cell immunity publication-title: Curr Top Microbiol Immunol – volume: 48 start-page: 2214 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib16 article-title: PD-L2 is expressed on activated human T cells and regulates their function publication-title: Mol Immunol doi: 10.1016/j.molimm.2011.06.436 – volume: 48 start-page: 488 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib47 article-title: PDCD1 single nucleotide genes polymorphisms confer susceptibility to juvenile-onset systemic lupus erythematosus publication-title: Autoimmunity doi: 10.3109/08916934.2015.1058370 – volume: 26 start-page: 677 year: 2008 ident: 10.1016/j.jfma.2020.04.004_bib8 article-title: PD-1 and its ligands in tolerance and immunity publication-title: Annu Rev Immunol doi: 10.1146/annurev.immunol.26.021607.090331 – volume: 44 start-page: 1299 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib116 article-title: Multicenter validation study of anti-programmed cell death-1 antibody as a serological marker for type 1 autoimmune hepatitis publication-title: Hepatol Res doi: 10.1111/hepr.12305 – volume: 69 start-page: 1879 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib25 article-title: Contribution of soluble forms of programmed death 1 and programmed death ligand 2 to disease severity and progression in systemic sclerosis publication-title: Arthritis Rheum doi: 10.1002/art.40164 – volume: 18 start-page: 1 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib92 article-title: Neuromuscular complications of programmed cell death-1 (PD-1) inhibitors publication-title: Curr Neurol Neurosci Rep doi: 10.1007/s11910-018-0878-7 – volume: 7 start-page: 161 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib57 article-title: Pathogenic role of immune cells in rheumatoid arthritis: implications in clinical treatment and biomarker development publication-title: Cells doi: 10.3390/cells7100161 – volume: 49 start-page: 1 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib17 article-title: PD-L2 is predominantly expressed by Th2 cells publication-title: Mol Immunol doi: 10.1016/j.molimm.2011.09.014 – volume: 188 start-page: 455 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib73 article-title: Inflammatory cytokines compromise programmed cell death-1 (PD-1)-mediated T cell suppression in inflammatory arthritis through up-regulation of soluble PD-1 publication-title: Clin Exp Immunol doi: 10.1111/cei.12949 – volume: 46 start-page: 371 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib30 article-title: The systemic activation of programmed death 1-PD-L1 axis protects systemic lupus erythematosus model from nephritis publication-title: Am J Nephrol doi: 10.1159/000480641 – volume: 542 start-page: 110 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib67 article-title: Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis publication-title: Nature doi: 10.1038/nature20810 – volume: 3 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib70 article-title: Rheumatic immune-related adverse events of checkpoint therapy for cancer: case series of a new nosological entity publication-title: RMD Open doi: 10.1136/rmdopen-2016-000412 – volume: 43 start-page: 307 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib41 article-title: Increased percentages of PD-1 on CD4+T cells is associated with higher INF-γ production and altered IL-17 production in patients with systemic lupus erythematosus publication-title: Scand J Rheumatol doi: 10.3109/03009742.2013.869830 – volume: 375 start-page: 1749 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib94 article-title: Fulminant myocarditis with combination immune checkpoint blockade publication-title: N Engl J Med doi: 10.1056/NEJMoa1609214 – volume: 2 start-page: 261 year: 2001 ident: 10.1016/j.jfma.2020.04.004_bib13 article-title: PD-L2 is a second ligand for PD-1 and inhibits T cell activation publication-title: Nat Immunol doi: 10.1038/85330 – volume: 19 start-page: 1 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib37 article-title: Elevated serum autoantibodies against co-inhibitory PD-1 facilitate T cell proliferation and correlate with disease activity in new-onset systemic lupus mcmc erythematosus patients publication-title: Arthritis Res Ther doi: 10.1186/s13075-017-1258-4 – volume: 30 start-page: 1181 year: 2011 ident: 10.1016/j.jfma.2020.04.004_bib104 article-title: Inverse correlation of programmed death 1 (PD-1) expression in T cells to the spinal radiologic changes in Taiwanese patients with ankylosing spondylitis publication-title: Clin Rheumatol doi: 10.1007/s10067-011-1721-6 – volume: 52 start-page: 557 year: 2007 ident: 10.1016/j.jfma.2020.04.004_bib81 article-title: Failure to confirm association between PDCD1 polymorphisms and rheumatoid arthritis in a Japanese population publication-title: J Hum Genet doi: 10.1007/s10038-007-0145-2 – volume: 29 start-page: 1 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib93 article-title: Neurologic complications of immune checkpoint inhibitors publication-title: J Neuro Oncol – volume: 62 start-page: 1702 year: 2010 ident: 10.1016/j.jfma.2020.04.004_bib34 article-title: Lower expression levels of the programmed death 1 receptor on CD4+CD25+ T cells and correlation with the PD-1.3A genotype in patients with systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.27417 – volume: 78 start-page: 101 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib68 article-title: Smoking activates cytotoxic CD8+ T cells and causes survivin release in rheumatoid arthritis publication-title: J Autoimmun doi: 10.1016/j.jaut.2016.12.009 – volume: 153 start-page: 145 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib11 article-title: Programmed death-1 pathway in cancer and autoimmunity publication-title: Clin Immunol doi: 10.1016/j.clim.2014.04.010 – volume: 190 start-page: 5402 year: 2013 ident: 10.1016/j.jfma.2020.04.004_bib27 article-title: Blockade of programmed death-1 in young (New Zealand black x New Zealand white)F1 mice promotes the suppressive capacity of CD4+ regulatory T cells protecting from lupus-like disease publication-title: J Immunol doi: 10.4049/jimmunol.1202382 – volume: 170 start-page: 1257 year: 2003 ident: 10.1016/j.jfma.2020.04.004_bib21 article-title: Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production publication-title: J Immunol doi: 10.4049/jimmunol.170.3.1257 – volume: 52 start-page: 1058 year: 2005 ident: 10.1016/j.jfma.2020.04.004_bib79 article-title: A new haplotype of PDCD1is associated with rheumatoid arthritis in Hong Kong Chinese publication-title: Arthritis Rheum doi: 10.1002/art.20966 – volume: 10 start-page: 7716 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib43 article-title: PD-L1-expressing neutrophils as a novel indicator to assess disease activity of rheumatoid arthritis publication-title: Int J Clin Exp Med – volume: 50 start-page: 770 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib54 article-title: Association of a programmed death 1 gene polymorphism with the development of rheumatoid arthritis, but not systemic lupus erythematosus publication-title: Arthritis Rheum doi: 10.1002/art.20040 – volume: 50 start-page: 1770 year: 2004 ident: 10.1016/j.jfma.2020.04.004_bib80 article-title: Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope publication-title: Arthritis Rheum doi: 10.1002/art.20280 – volume: 96 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib82 article-title: Are programmed cell death 1 gene polymorphisms correlated with susceptibility to rheumatoid arthritis? publication-title: Medicine doi: 10.1097/MD.0000000000007805 – volume: 290 start-page: 72 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib14 article-title: The PD-1/PD-Ls pathway and autoimmune diseases publication-title: Cell Immunol doi: 10.1016/j.cellimm.2014.05.006 – volume: 52 start-page: 93 year: 2017 ident: 10.1016/j.jfma.2020.04.004_bib22 article-title: Soluble programmed death-1 levels are associated with disease activity and treatment response in patients with autoimmune hepatitis publication-title: Scand J Gastroenterol doi: 10.1080/00365521.2016.1233576 – volume: 6 start-page: 1 year: 2016 ident: 10.1016/j.jfma.2020.04.004_bib83 article-title: Endogenous programmed death ligand-1 restrains the development and onset of Sjӧgren’s syndrome in non-obese diabetic mice publication-title: Sci Rep doi: 10.1038/srep39105 – volume: 29 start-page: 110 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib117 article-title: Anti-programmed cell death-1 antibody as a new serological marker for type 1 autoimmune hepatitis publication-title: J Gastroenterol Hepatol doi: 10.1111/jgh.12340 – volume: 70 start-page: 566 year: 2018 ident: 10.1016/j.jfma.2020.04.004_bib88 article-title: Increased expression and modulated regulatory activity of coinhibitory receptors PD-1, TIGIT, and TIM-3 in lymphocytes from patients with systemic sclerosis publication-title: Arthritis Rheum doi: 10.1002/art.40399 – volume: 523 start-page: 612 year: 2015 ident: 10.1016/j.jfma.2020.04.004_bib38 article-title: T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection publication-title: Nature doi: 10.1038/nature14468 – volume: 13 start-page: 4031 year: 2012 ident: 10.1016/j.jfma.2020.04.004_bib24 article-title: Reconstructed adeno-associated virus with the extracellular domain of murine PD-1 induces antitumor immunity publication-title: Asian Pac J Cancer Prev APJCP doi: 10.7314/APJCP.2012.13.8.4031 – volume: 43 start-page: 101 year: 2014 ident: 10.1016/j.jfma.2020.04.004_bib23 article-title: Increased soluble programmed death-1 (sPD-1) is associated with disease activity and radiographic progression in early rheumatoid arthritis publication-title: Scand J Rheumatol doi: 10.3109/03009742.2013.823517 |
| SSID | ssj0046996 |
| Score | 2.3858473 |
| SecondaryResourceType | review_article |
| Snippet | Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues. Programmed death-1 (PD-1)... Background/purpose: Autoimmune diseases are diseases in which the body produces an abnormal immune response to self-antigens and damages its own tissues.... |
| SourceID | doaj proquest pubmed crossref elsevier |
| SourceType | Open Website Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 48 |
| SubjectTerms | Animals Autoimmunity B7-H1 Antigen Genetic susceptibility Humans Pathogenesis Pathway Programmed Cell Death 1 Receptor - genetics Programmed death-1 Rheumatic diseases Rheumatic Diseases - genetics |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals - May need to register for free articles dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LS8QwEA7iQbyIb9cXFbxJsXm1ydEni7jiQcFbSNIpKlJFdxH_vZM0XfSgXrzkUDpt802SmTQz3xCyT52vPPAqbygXuaBO567WKrdKaFsr29QxQ250VQ5vxcWdvPtS6ivEhHX0wB1wh6IUTnrrlFNKMOdcDa7B6W2FK9E5jql7aPP6zVS3BuOeL1bmKnQI7ihFmdJlusiuxyYyDrEikpymEm29SYrM_d8s00-eZ7RA54tkIbmO2VH3yUtkBtplMjdKh-MrJERPZNenOT3E5jILtYbf7Uf20Gav9zCJ1KxZOo95WyW352c3J8M81ULIvaTVOLelqKD0llr0CdAog5ZWN95WnAK2VY0wCQ0FyFqiGQbPGaJcKaAQbFDN18hs-9zCBslEVYJmNTCP2KKUY4FzTDpufWG94gNCeziMT0ThoV7Fk-kjwh5NgNAECE0hDEI4IAdTmZeOJuPXu48DytM7A8V1vICKN0nx5i_FDwjvdWT6LFJc9_BBD7--Wk6lko_R-Q5_yu31w8DgBAynKraF58mbYVxL3ENKqgZkvRsf045xxrlAB3zzPzq8ReZZCKiJ_3-2yez4dQI76BGN3W4c_J_4FwOU priority: 102 providerName: Directory of Open Access Journals |
| Title | The PD-1/PD-L pathway in rheumatic diseases |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0929664620301248 https://dx.doi.org/10.1016/j.jfma.2020.04.004 https://www.ncbi.nlm.nih.gov/pubmed/32334916 https://www.proquest.com/docview/2395259518 https://doaj.org/article/464b5cab8b8842bbbdebf146a4b61189 |
| Volume | 120 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3NaxUxEA-lB_Eifvv8KCt4k_g2yWQ3OWq1FLEiaKG3kGSz-krZV17fQ7z4tzuTzS70YAUvewiTTXYyOzNJZn7D2CsRYhuTankvFHAQwfLQWcO9Aes74_suZ8idfG6OT-HjmT7bY4dTLgyFVRbdP-r0rK1Ly7Jwc3m5Wi2_1mjZmwYaSV69BEr4BWhJyt_8nsM8cPeXa3QRMSfqkjgzxnid9xl7SNYZ7rQUa5uMU8bwv2aj_uaDZlt0dJfdKU5k9Xac5z22l4b77NZJuSZ_wCiOovrynoslPj5VVHX4p_9VrYZq8yPtMkhrVW5mrh6y06MP3w6PeamKwKMW7Zb7BtrURC88egdonpPV3vbRt0okfLZdAwFsqpPuNBrkFJVEfrcmiUTWqFOP2P6wHtITViG3kpVdkhHQLQoQJKGP6aB8rH00asHExA4XC2Q4Va64cFNs2LkjFjpioavBIQsX7PXc53IEzLiR-h1xeaYksOvcsN58d2W1HU4u6OiDCcaADCF0KfSo4T2EBvdHdsHUtEZuyidFDYgvWt04tJ57XZO4f_Z7OYmBw1-R7lf8kNa7KyeV1bib1MIs2ONRPuYPU1IpQFf86X-O-ozdlhRNkw9_nrP97WaXXqA7tA0HWd4P8mHCH_6dBAg |
| linkProvider | Elsevier |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtR3JbtQw9KkUCbhUrGUoS5DghMLEW-IcegBKNaUzFRKt1JuxHQemQplqFlW99Kf6g312nEg9UCSkXnywvLw8P78lfgvAO2JsYR0r0pownnJiytRUpUy15KWupK6rECE3OchHR_zbsTheg8suFsa7VUbe3_L0wK1jzzBic3g6nQ5_ZCjZ85zn1Gv1lMvoWbnvzs_Qblts7-3gIb-ndPfr4ZdRGksLpFaQYpnqnBcut5poFLEo41wpdFlbXTDisC2qnBteusyJSqBUc5ZRBLqQjjjP0iuG696BuxzZhS-b8PGi9ytBczMUBfPQpR68GKnTOpWd1CHZEc1CftVYHa6ThqFowDWh-DelNwi_3YewEbXW5FOLmEew5prHcG8S3-WfgHfcSL7vpGSIzTjxZY7P9HkybZL5b7cKWWGT-BS0eApHt4KrZ7DezBr3HBJe5K6klaOWox5muKE-3ZkwTNtMW8kGQDp0KBtzlPtSGX9U54x2ojwKlUehyrhCFA7gQz_ntM3QcePozx7L_UifXTt0zOa_VCQvhcAZYbWRRkpOjTGVMzWKFM1NjgZZOQDWnZHqAliR5eJC0xu3Fv2sayT-z3lvOzJQePf9g45u3Gy1UJSVAs1XQeQANlv66D-MUcY46v4v_nPXN3B_dDgZq_Hewf4WPKDelSf8eXoJ68v5yr1CXWxpXgfaT-DnbV-2K1GNQAk |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+PD-1%2FPD-L+pathway+in+rheumatic+diseases&rft.jtitle=Journal+of+the+Formosan+Medical+Association&rft.au=Zhang%2C+Shuo&rft.au=Wang%2C+Li&rft.au=Li%2C+Mengtao&rft.au=Zhang%2C+Fengchun&rft.date=2021-01-01&rft.issn=0929-6646&rft.volume=120&rft.issue=1+Pt+1&rft.spage=48&rft_id=info:doi/10.1016%2Fj.jfma.2020.04.004&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0929-6646&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0929-6646&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0929-6646&client=summon |